This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

A National Registry of Patients With Hepatocellular Carcinoma

This study has been completed.
Information provided by:
Vanderbilt University Identifier:
First received: September 12, 2005
Last updated: October 9, 2008
Last verified: October 2008
A registry of patients with the diagnosis of hepatocellular carcinoma.

Carcinoma, Hepatocellular

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: A National Registry of Patients With Hepatocellular Carcinoma

Further study details as provided by Vanderbilt University:

Enrollment: 150
Study Start Date: January 2002
Study Completion Date: August 2008
Detailed Description:
The purpose of this research is to study the factors which might cause hepatocellular carcinoma (a form of cancer arising within the liver) and compare these factors in patients from different ethnic groups and from different parts of the United States. The researchers will also conduct a survey of the stage of the cancer (how far advanced it is) and what treatments are used for this difficult-to-treat tumor.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients seen in Hepatobiliary Surgery Clinic at Vanderbilt University Medical Center who are diagnosed with hepatocellular carcinoma.

Inclusion Criteria:

  • Patients with diagnosis of hepatocellular carcinoma

Exclusion Criteria:

  • Patients can not be under 18 years of age
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00178867

United States, Tennessee
Vanderbilt University
Nashville, Tennessee, United States, 37232-4753
Sponsors and Collaborators
Vanderbilt University
Principal Investigator: Ravi S Chari, MD Vanderbilt University
  More Information

Responsible Party: Ravi Chari, MD, Vanderbilt University Identifier: NCT00178867     History of Changes
Other Study ID Numbers: 020116
Study First Received: September 12, 2005
Last Updated: October 9, 2008

Additional relevant MeSH terms:
Carcinoma, Hepatocellular
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Liver Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Liver Diseases processed this record on August 16, 2017